- Home
- ACON vs RSLS Comparison
ACON vs RSLS Comparison
Compare ACON & RSLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACON
- RSLS
- Stock Information
- Founded
- ACON 2008
- RSLS 2002
- Country
- ACON United States
- RSLS United States
- Employees
- ACON N/A
- RSLS N/A
- Industry
- ACON Retail: Computer Software & Peripheral Equipment
- RSLS Medical/Dental Instruments
- Sector
- ACON Technology
- RSLS Health Care
- Exchange
- ACON Nasdaq
- RSLS Nasdaq
- Market Cap
- ACON 4.8M
- RSLS 4.5M
- IPO Year
- ACON 2022
- RSLS 2007
- Fundamental
- Price
- ACON $7.64
- RSLS $0.38
- Analyst Decision
- ACON Buy
- RSLS Hold
- Analyst Count
- ACON 2
- RSLS 1
- Target Price
- ACON $481.00
- RSLS N/A
- AVG Volume (30 Days)
- ACON 75.1K
- RSLS 44.2M
- Earning Date
- ACON 04-09-2025
- RSLS 04-04-2025
- Dividend Yield
- ACON N/A
- RSLS N/A
- EPS Growth
- ACON N/A
- RSLS N/A
- EPS
- ACON N/A
- RSLS N/A
- Revenue
- ACON $45,724.00
- RSLS $8,006,000.00
- Revenue This Year
- ACON $251.35
- RSLS $52.80
- Revenue Next Year
- ACON N/A
- RSLS N/A
- P/E Ratio
- ACON N/A
- RSLS N/A
- Revenue Growth
- ACON N/A
- RSLS N/A
- 52 Week Low
- ACON $7.26
- RSLS $0.30
- 52 Week High
- ACON $6,241.05
- RSLS $29.00
- Technical
- Relative Strength Index (RSI)
- ACON 33.40
- RSLS 42.48
- Support Level
- ACON $8.15
- RSLS $0.37
- Resistance Level
- ACON $8.30
- RSLS $0.49
- Average True Range (ATR)
- ACON 1.25
- RSLS 0.11
- MACD
- ACON 6.41
- RSLS 0.04
- Stochastic Oscillator
- ACON 6.94
- RSLS 19.28
About ACON Aclarion Inc.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.
About RSLS ReShape Lifesciences Inc.
Reshape Lifesciences Inc is a medical device company focused on technologies to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, ReShapeCare virtual health coaching program, ReShape Market Place, including ReShape Optimize a supplemental multivitamin, the Obalon Balloon System, the first and only swallowable gas-filled balloon system, and the Diabetes Bloc-Stim Neuromodulation, a technology under development as a new treatment for type 2 diabetes mellitus. Geographically, the company operates in the United States, Australia, Europe, and the Rest of world, and the majority of its revenue is generated from the United States.